+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of short-term use of nocturnal nasal continuous positive airway pressure for a clinical profile and exercise capacity in adult patients with obstructive sleep apnea-hypopnea syndrome



Evaluation of short-term use of nocturnal nasal continuous positive airway pressure for a clinical profile and exercise capacity in adult patients with obstructive sleep apnea-hypopnea syndrome



Lung India 32(3): 225-232



The obstructive sleep apnea-hypopnea syndrome (OSAHS) is a common chronic respiratory disease, characterized by repetitive complete or partial collapse of the upper airway during sleep. The clinical spectrum extends between stoppage of breathing, snoring, daytime somnolence, and fatigue, to serious cardiovascular disease, stroke, metabolic syndrome, increased morbidity, and mortality. We aim to evaluate the short-term use of nasal continuous positive airway pressure (nCPAP) therapy for the clinical profile and exercise capacity of patients with OSAHS. Twenty patients diagnosed with moderate-to-severe OSAHS were enrolled in the study (study group - 15; clinically and PSG-matched control group - 5). Each patient was clinically evaluated for sleep-related symptoms, and also assessed with spirometry, the six-minute walk test (6MWT), and a symptom-limited incremental cardiopulmonary exercise test (CPET). The study group patients were administered nCPAP therapy for eight hours each night for four weeks, while the control group patients were just observed. They were re-assessed after four weeks and the data were statistically analyzed between the two groups. The study group patients showed a significant (P- < 0.05) improvement in the OSAHS symptoms-the Epworth sleepiness score, six-minute walk distance; duration of exercise, power output, peak oxygen uptake, anaerobic threshold, diastolic blood pressure, dyspnea, and fatigue-in comparison with the control group patients. The improvement in exercise capacity following nCPAP therapy was attributed to the relief of disabling the OSAHS symptoms and improved cardiovascular, ventilator, and musculoskeletal functions. All OSAHS patients must be treated with nCPAP.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057816021

Download citation: RISBibTeXText

PMID: 25983407

DOI: 10.4103/0970-2113.156226


Related references

Short-term and long-term influences of nasal continuous positive airway pressure to sleep architecture of obstructive sleep apnea hypopnea syndrome. Zhonghua Nei Ke Za Zhi 43(9): 651-653, 2004

Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 30(6): 666-669, 2005

Effects of long term nasal continuous positive airway pressure on the blood pressure of patients with obstructive sleep apnea hypopnea syndrome. Zhonghua Jie he He Hu Xi Za Zhi 35(9): 687-690, 2012

Effects of short-term continuous positive airway pressure treatment on arterial stiffness in patients with obstructive sleep apnea hypopnea syndrome. Zhonghua Yi Xue Za Zhi 88(17): 1189-1191, 2008

Evaluation of the apnea-hypopnea index determined by the S8 auto-CPAP, a continuous positive airway pressure device, in patients with obstructive sleep apnea-hypopnea syndrome. Journal of Clinical Sleep Medicine 6(2): 146-151, 2010

Improvement of exercise performance with short-term nasal continuous positive airway pressure in patients with obstructive sleep apnea. Tohoku Journal of Experimental Medicine 183(1): 45-53, 1997

Improvement of Exercise Performance with Short-Term Nasal Continuous Positive Airway Pressure in Patients with Obstructive Sleep Apnea. The Tohoku Journal of Experimental Medicine 183(1): 45-53, 1997

Effect of continuous positive airway pressure treatment on short-term memory performance over 24 h of sustained wakefulness in patients with obstructive sleep apnea-hypopnea syndrome. Sleep Medicine 14(10): 964-972, 2013

Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 127(3): 710-715, 2005

Relationship between the reduction of hemoglobin and hematocrit, and nocturnal urine volume in obstructive sleep apnea patients after short-term nasal continuous positive airway pressure therapy. Togawa, K, Katayama, S, Hishikawa, Y, Ohto, Y, Horie, T Sleep apnea and rhonchopathy: 49-55, 1993

Impact of nasal continuous positive airway pressure on heart rhythm in patients with obstructive sleep apnea/hypopnea syndrome. Minerva Medica 105(3): 255-260, 2014

Adverse effects and adherence to nasal continuous positive airway pressure in patients with obstructive sleep apnea hypopnea syndrome. Nihon Kokyuki Gakkai Zasshi 42(2): 127-131, 2004

Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta-analysis of clinical trials. Zhonghua Yi Xue Za Zhi 87(17): 1177-1180, 2007

Validity Of Apnea-Hypopnea Index Determined By Autotitrating Continuous Positive Airway Pressure Device In Patients With Obstructive Sleep Apnea-Hypopnea Syndrome. Chest 132(4): 648-1, 2007

Clinical predictors of effective continuous positive airway pressure in patients with obstructive sleep apnea/hypopnea syndrome. Laryngoscope 125(8): 1983-1987, 2015